Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)

NCT ID: NCT04390178 Phase: PHASE1 Status: COMPLETED Enrollment: 10 Completion: 2020-12-31

Conditions

COVID-19

Interventions

SARS-CoV-2 convalescent plasma

Summary

There is currently no effective treatment for COVID-19 except best supportive care. The aim is assess the safety, tolerability and efficacy of convalescent plasma for treatment of patients with varying degrees of COVID-19 illness.

Primary Outcome

Disease progression

Source

ClinicalTrials.gov